Simplex Trading’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$867 Sell
3,300
-1,000
-23% -$278 ﹤0.01% 8627
2025
Q4
$1.21K Buy
+4,300
New +$1.53K ﹤0.01% 7983
2024
Q1
Sell
-106,100
Closed -$29K 9294
2023
Q4
$29K Sell
106,100
-1,800
-2% -$558 ﹤0.01% 6590
2023
Q3
$38K Sell
107,900
-1,800
-2% -$644 ﹤0.01% 6051
2023
Q2
$34K Sell
109,700
-1,000
-0.9% -$324 ﹤0.01% 6220
2023
Q1
$37K Sell
110,700
-49,600
-31% -$18.6K ﹤0.01% 6255
2022
Q4
$50K Sell
160,300
-8,900
-5% -$3.63K ﹤0.01% 5901
2022
Q3
$72K Buy
169,200
+5,300
+3% +$2.82K ﹤0.01% 5949
2022
Q2
$86K Buy
163,900
+70,900
+76% +$44.7K ﹤0.01% 5769
2022
Q1
$88K Sell
93,000
-39,000
-30% -$37.9K ﹤0.01% 6328
2021
Q4
$128K Buy
132,000
+39,400
+43% +$52.9K ﹤0.01% 5861
2021
Q3
$159K Sell
92,600
-7,200
-7% -$11.6K ﹤0.01% 5962
2021
Q2
$163K Buy
99,800
+99,661
+71,699% +$152K ﹤0.01% 6018
2021
Q1
$24K Sell
139
-174
-56% -$316 ﹤0.01% 7305
2020
Q4
$48K Buy
313
+293
+1,465% +$433 ﹤0.01% 6221
2020
Q3
$2K Buy
+20
New +$20 ﹤0.01% 7419
2019
Q4
Sell
-57
Closed -$5K 7575
2019
Q3
$5K Sell
57
-81
-59% -$97 ﹤0.01% 6604
2019
Q2
$22K Buy
138
+115
+500% +$162 ﹤0.01% 5532
2019
Q1
$4K Buy
+23
New +$52 ﹤0.01% 6563

Other funds holding IGC

Simplex Trading's IGC Position: Q4 2025 in Review

Simplex Trading sold out of IGC Pharma (IGC) in Q4 2025, closing a stake of 212 shares — an estimated $76 sold.

Simplex Trading first reported a position in IGC in Q4 2018 and held it in 20 quarters. The position peaked at $155K in Q1 2021. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

  • Simplex Trading reported no remaining IGC Pharma position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 212 IGC Pharma shares in Q4 2025, an estimated $76.
  • Simplex Trading first reported a position in IGC Pharma in Q4 2018 and held it in 20 quarters.
  • Simplex Trading's IGC Pharma position peaked at $155K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.